AEPGX
Price
$62.02
Change
-$0.23 (-0.37%)
Updated
Aug 29 closing price
Net Assets
134.64B
TIGVX
Price
$24.80
Change
-$0.12 (-0.48%)
Updated
Aug 29 closing price
Net Assets
734.8M
Interact to see
Advertisement

AEPGX vs TIGVX

Header iconAEPGX vs TIGVX Comparison
Open Charts AEPGX vs TIGVXBanner chart's image
American Funds EUPAC A
Price$62.02
Change-$0.23 (-0.37%)
VolumeN/A
Net Assets134.64B
Thornburg International Growth R3
Price$24.80
Change-$0.12 (-0.48%)
VolumeN/A
Net Assets734.8M
AEPGX vs TIGVX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AEPGX vs. TIGVX commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPGX is a Buy and TIGVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPGX has more cash in the bank: 135B vs. TIGVX (735M). AEPGX pays higher dividends than TIGVX: AEPGX (0.70) vs TIGVX (0.00). AEPGX was incepted earlier than TIGVX: AEPGX (41 years) vs TIGVX (18 years). TIGVX (2.18) is less costly to investors than AEPGX (0.83). TIGVX is a more actively managed with annual turnover of: 44.57 vs. AEPGX (35.00). TIGVX has a lower initial minimum investment than AEPGX: TIGVX (0) vs AEPGX (250). AEPGX annual gain was more profitable for investors over the last year : 5.32 vs. TIGVX (-6.35). AEPGX return over 5 years is better than : 9.13 vs. TIGVX (-11.87).
AEPGXTIGVXAEPGX / TIGVX
Total Expense Ratio0.831.5055%
Annual Report Gross Expense Ratio0.832.1838%
Fund Existence41 years18 years-
Gain YTD15.45011.599133%
Front Load6%N/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets135B735M18,367%
Annual Yield % from dividends0.700.00-
Returns for 1 year5.32-6.35-84%
Returns for 3 years31.4924.35129%
Returns for 5 years9.13-11.87-77%
Returns for 10 years41.9940.64103%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACHC22.960.34
+1.50%
Acadia Healthcare Company
TCRT2.130.03
+1.43%
Alaunos Therapeutics Inc.
OWL18.52-0.17
-0.91%
Blue Owl Capital
AQST3.77-0.06
-1.57%
Aquestive Therapeutics
PYXS1.28-0.05
-3.76%
Pyxis Oncology